Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This is the first pharmacological agent to show prognostic benefit in this population, offering therapeutic potential beyond symptomatic control
After removing duplicates and screening titles and abstracts, 170 studies were assessed for full-text eligibility
(2017) Riboflavin has neuroprotective potential: focus on Parkinsons disease and migraine
According to the SmPC, if a patient does not tolerate a dose increase, delaying the increase by an additional 4 weeks can be considered
US$ 21.78
US$ 25.41
US$ 25.93
US$ 24.23
US$ 23.23
US$ 27.65
